These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32124493)

  • 1. Osteoporosis and bone health in autoimmune blistering skin disease-an evidenced based review.
    Kang M; Bilgic A; Radjenovic M; Murrell DF
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2745-2756. PubMed ID: 32124493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of autoimmune blistering disease, and specifically, pemphigus vulgaris, with cardiovascular disease and its risk factors: a systematic review and meta-analysis.
    Rokni AM; Ayasse M; Ahmed A; Guggina L; Kantor RW; Silverberg JI
    Arch Dermatol Res; 2023 Mar; 315(2):207-213. PubMed ID: 35262797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases.
    Lee BWH; Tan JCK; Radjenovic M; Coroneo MT; Murrell DF
    Orphanet J Rare Dis; 2018 May; 13(1):83. PubMed ID: 29789014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of case-control studies on the risk factors for the development of autoimmune blistering diseases.
    Oh DD; Zhao CY; Murrell DF
    J Eur Acad Dermatol Venereol; 2016 Apr; 30(4):595-603. PubMed ID: 26434420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blistering diseases in the mature patient.
    Lakoš Jukić I; Jerković Gulin S; Marinović B
    Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models to investigate pathomechanisms and evaluate novel treatments for autoimmune bullous dermatoses.
    Iwata H; Bieber K; Hirose M; Ludwig RJ
    Curr Pharm Des; 2015; 21(18):2422-39. PubMed ID: 25777758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid use in autoimmune blistering diseases.
    Frew JW; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):535-44. PubMed ID: 21924995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome measures for autoimmune blistering diseases.
    Zhao CY; Murrell DF
    J Dermatol; 2015 Jan; 42(1):31-6. PubMed ID: 25558950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatomyositis in patients with autoimmune blistering diseases.
    Patsatsi A; Pearson DR; Werth VP
    Int J Womens Dermatol; 2019 Sep; 5(4):256-260. PubMed ID: 31700982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal Autoimmune Blistering Disease: A Systematic Review.
    Zhao CY; Chiang YZ; Murrell DF
    Pediatr Dermatol; 2016 Jul; 33(4):367-74. PubMed ID: 27086740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid.
    Kowalski EH; Kneibner D; Kridin K; Amber KT
    Autoimmun Rev; 2019 May; 18(5):526-534. PubMed ID: 30844553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D status in patients with autoimmune bullous dermatoses: a meta-analysis.
    Yang M; Wu H; Zhao M; Long H; Lu Q
    J Dermatolog Treat; 2022 May; 33(3):1356-1367. PubMed ID: 32799714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and pathogenesis of osteopenia and osteoporosis in epidermolysis bullosa: An evidence-based review.
    Chen JS; Yang A; Murrell DF
    Exp Dermatol; 2019 Oct; 28(10):1122-1130. PubMed ID: 30118182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of autoimmune bullous diseases among children in Kuwait.
    Nanda A; Lazarevic V; Rajy JM; Almasry IM; AlSabah H; AlLafi A
    Pediatr Dermatol; 2021 Jan; 38(1):50-57. PubMed ID: 33043506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune blistering skin diseases triggered by COVID-19 vaccinations: An Australian case series.
    Cowan TL; Huang C; Murrell DF
    Front Med (Lausanne); 2022; 9():1117176. PubMed ID: 36703892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia in Autoimmune Blistering Diseases: A Systematic Review of Pathogenesis and Clinical Features of Disease.
    Xie D; Bilgic-Temel A; Abu Alrub N; Murrell DF
    Skin Appendage Disord; 2019 Aug; 5(5):263-275. PubMed ID: 31559249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatigue in systemic lupus erythematosus and other autoimmune skin diseases.
    Tarazi M; Gaffney RG; Pearson D; Kushner CJ; Werth VP
    Br J Dermatol; 2019 Jun; 180(6):1468-1472. PubMed ID: 30269332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-of-the-art review of human autoimmune blistering diseases (AIBD).
    Zeng FAP; Murrell DF
    Vet Dermatol; 2021 Dec; 32(6):524-e145. PubMed ID: 34351020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Clinical Trials in Pemphigus and Pemphigoid.
    Izumi K; Bieber K; Ludwig RJ
    Front Immunol; 2019; 10():978. PubMed ID: 31130959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases.
    van Beek N; Dähnrich C; Johannsen N; Lemcke S; Goletz S; Hübner F; Di Zenzo G; Dmochowski M; Drenovska K; Geller S; Horn M; Kowalewski C; Medenica L; Murrell DF; Patsatsi A; Uzun S; Vassileva S; Zillikens D; Schlumberger W; Schmidt E
    J Am Acad Dermatol; 2017 May; 76(5):889-894.e5. PubMed ID: 28038887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.